Abstract
This investigation explored the nilotinib action in the management of acute pancreatitis (AP) and AP-induced lung and liver injury. AP was induced in Sprague Dawley (SD) rats with L-arginine. Treatment with nilotinib with or without L-arginine was applied for 7 days. Marked deterioration in serum amylase, lipase, aspartate amino transferase (AST), alanine amino transferase (ALT), lactate dehydrogenase (LDH), nitric oxide (NO), total protein content, and transforming growth factor beta1 (TGF-β1) along with pancreatic, hepatic, and pulmonary tissue lipid peroxidation (MDA) after induction of AP while significant reduction in tissues superoxide dismutase (SOD), glutathione (GSH) with marked edema, hemorrhage, and perivascular inflammation with acinar cell necrosis, along with elevated pancreatic percentage expression of TGF-β1 and nuclear factor kappa B (NF-κB), were observed in the AP group. Nilotinib markedly ameliorated biochemical and histopathologic changes during AP, thus preserving the pancreas, liver, and lung histologically through mechanism involving antioxidant and anti-inflammatory actions.
Similar content being viewed by others
References
Akbarshahi H, Sam A, Chen C, Rosendahl AH, Andersson R (2014) Early activation of pulmonary TGF-β1/Smad2 signaling in mice with acute pancreatitis-associated acute lung injury. Mediat Inflamm 2014:148029. doi:10.1155/2014/148029
Akhmetshina A, Dees C, Pileckyte M, Maurer B, Axmann R, Jüngel A, Zwerina J, Gay S, Schett G, Distler O, Distler JH (2008) Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis. FASEB J 22:2214–2222
Andican G, Gelisgen R, Unal E, Tortum OB, Dervisoglu S, Karahasanoglu T, Burçak G (2005) Oxidative stress and nitric oxide in rats with alcohol-induced acute pancreatitis. World J Gastroenterol 11(15):2340–2345
Baddeley R, Skipworth J, Pereia S (2010) Acute pancreatitis. Medicine 39:108–115
Balachandra S, Genovese T, Mazzon E, Di Paola R, Thiemerman C, Siriwardena AK, Cuzzocrea S (2005) Inhibition of tyrosine-kinase mediated cellular signaling by tyrphostins AG 126 and AG556 modulates murine experimental acute pancreatitis. Surgery 138:913–923
Bradley EL (1993) A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 128:586–590
Breccia M, Alimena G (2010) Nilotinib: a second-generation tyrosine kinase inhibitor for chronic myeloid leukemia. Leuk Res 34:129–134
Campo GM, Avenoso A, Campo S, Nastasi G, Traina P, D’ Ascola A, Calatroni A (2008) Chondroitin-4- sulphate reduced oxidative injury in caerulein-induced pancreatitis in mice: the involvement of NF-kappaB translocation and apoptosis activation. Exp Biol Med (Maywood) 233:741–752
Cappell SM (2008) Acute pancreatitis: etiology, clinical presentation, diagnosis, and therapy. Med Clin N Am 92:889–923
Cuzzocrea S, Mazzon E, Dugo L, Serraino I, Centorrino T, Ciccolo A, Van de Loo FA, Britti D, Caputi AP, Thiemermann C (2002) Inducible nitric oxide synthase-deficient mice exhibit resistance to the acute pancreatitis induced by cerulein. Shock 17:416–422
Czako L, Takacs T, Varga IS, Hai DQ, Tiszlavicz L, Hegyi P, Mandi Y, Matkovics B, Lonovics J (2000) The pathogenesis of L-arginine-induced acute necrotizing pancreatitis: inflammatory mediators and endogenous cholecystokinin. J Physiol Paris 94:43–50
Dabrowski A, Konturek SJ, Konturek JW, Gabryelewicz A (1999) Role of oxidative stress in the pathogenesis of caerulein-induced acute pancreatitis. Eur J Pharmacol 377:1–11
Day E, Waters B, Spiegel K, Alnadaf T, Manley PW, Buchdunger E, Walker C, Jarai G (2008) Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib. Eur J Pharmacol 599:44–53
DiDonato JA, Mercurio F, Karin M (1995) Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B. Mol Cell Biol 15:1302–1311
El-Agamy DS (2011) Nilotinib ameliorates lipopolysaccharide-induced acute lung injury in rats. Toxicol Appl Pharmacol 253:153–160
Elsherbiny NM, El-Sherbiny M, Said E (2015) Amelioration of experimentally induced diabetic nephropathy and renal damage by nilotinib. J Physiol Biochem 71:635–648
Engel T, Justo D, Amitai M, Volchek Y, Mayan H (2013) Nilotinib-associated acute pancreatitis. Ann Pharmacother 47:e3
Gomez-Cambronero LG, Sabater L, Pereda J, Cassinello N, Camps B, Vina J, Sastre J (2002) Role of cytokines and oxidative stress in the pathophysiology of acute pancreatitis: therapeutical implications. Curr Drug Targets Inflamm Allergy 1:393–403
Gray KD, Simovic MO, Chapman WC, Blackwell TS, Christman JW, Washington MK, Yull FE, Jaffal N, Jansen ED, Gautman S, Stain SC (2003) Systemic NF-kappa B activation in a transgenic mouse model of acute pancreatitis. J Surg Res 110:310–314
Greer SE, Burchard MW (1993) Acute pancreatitis and critical illness: a pancreatic tale of hypoperfusion and inflammation. Chest 136:1413–1419
Guesdon JL, Ternynck T, Avrameas S (1979) The use of avidin biotin interaction in immune-enzymatic techniques. J Histochem Cytochem 27:1131–1139
Harper SJ, Cheslyn-Curtis S (2011) Acute pancreatitis. Ann Clin Biochem 48:23–37
Iyoda M, Shibata T, Hirai Y, Kuno Y, Akizawa T (2011) Nilotinib attenuates renal injury and prolongs survival in chronic kidney disease. J Am Soc Nephrol 22:1486–1496
Johnson JR, Bross P, Cohen M, Rothmann M, Chen G, Zajicek A, Gobburu J, Rahman A, Staten A, Pazdur R (2003) Approval summary: imatinib mesylate capsules for treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase. Clin Cancer Res 9:1972–1979
Jungermann J, Lerch MM, Weidenbach H, Lutz MP, Krüger B, Adler G (1995) Disassembly of rat pancreatic acinar cell cytoskeleton during supramaximal secretagogue stimulation. Am J Phys 268:G328–G338
Kaska M, Pospisilova B, Slizova D (2000) Pathomorphological changes in microcirculation of pancreas during experimental acute pancreatitis. Hepatogastroenterol 47:1570–1574
Kaur J, Sidhu S, Chopra K, Khan MU (2016) Calendula officinalis ameliorates l-arginine-induced acute necrotizing pancreatitis in rats. Pharm Biol 23:1–9
Khan AS, Latif SU (2010) Controversies in the etiologies of acute pancreatitis. JOP. 11:545–552
Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431–435
Koksel O, Yildirim C, Cinel L, Tamer L, Ozdulger A, Bastürk M, Degirmenci U, Kanik A, Cinel I (2005) Inhibition of poly (ADP-ribose) polymerase attenuates lung tissue damage after hind limb ischemia-reperfusion in rats. Pharmacol Res 51:453–462
Kumar S, Mishra N, Raina D, Saxena S, Kufe D (2003) Abrogation of the cell death response to oxidative stress by the c-abl tyrosine kinase inhibitor STI571. Mol Pharmacol 63(2):276–282
Liu X, Yu M, Chen Y, Zhang J (2016) Galunisertib (LY2157299), a transforming growth factor-β receptor I kinase inhibitor, attenuates acute pancreatitis in rats. Braz J Med Biol Res 49:e5388
Luttenberger T, Schmid-Kotsas A, Menke A, Siech M, Beger H, Adler G, Grünert A, Bachem MG (2000) Platelet-derived growth factors stimulate proliferation and extracellular matrix synthesis of pancreatic stellate cells: implications in pathogenesis of pancreas fibrosis. Lab Investig 80:47–55
Manley PW, Drueckes P, Fendrich G, Furet P, Liebetanz J, Martiny-Baron G, Mestan J, Trappe J, Wartmann M, Fabbro D (2010) Extended kinase profile and properties of the protein kinase inhibitor nilotinib. Biochim Biophys Acta 1804:445–453
Markowitz SD, Roberts AB (1996) Tumor suppressor activity of the TGF-beta pathway in human cancers. Cytokine Growth Factor Rev 7:93–102
Mirmalek SA, Gholamrezaei-Boushehrinejad A, Yavari H, Kardeh B, Parsa Y, Salimi-Tabatabaee SA, Yadollah-Damavandi S, Parsa T, Shahverdi E, Jangholi E (2016) Antioxidant and anti-inflammatory effects of coenzyme Q10 on L-arginine-induced acute pancreatitis in rat. Oxidative Med Cell Longev . doi:10.1155/2016/58184795818479
Mizuguchi T, Mukaiya M, Imaizumi H, Kimura Y, Ma-suda Y, Katsuramaki T, Asai Y, Hirata K (2004) Successful management of severe acute pancreatitis with multiple organ failure. Pancreas 28:211–213
Mizunuma T, Kawamura S, Kishino Y (1984) Effects of injecting excess arginine on rat pancreas. J Nutr 114:467–471
Nader MA, Attia GM (2016) Beneficial effects of nilotinib, tyrosine kinase inhibitor on cyclosporine-a induced renal damage in rats. Int Immunopharmacol 33:1–7
Nandy D, Mukhopadhyay D (2011) Growth factor mediated signaling in pancreatic pathogenesis. Cancers (Basel) 3:841–871
National Research Council (US) (2011) Committee for the update of the guide for the care and use of laboratory animals. Guide for the care and use of laboratory animals, 8th edition. Washington (DC): National Academies Press (US). 2, Animal care and use program. Available from: http://www.ncbi.nlm.nih.gov/books/NBK54045/
Pezzilli R, Corinaldesi R, Morselli-Labate AM (2010) Tyrosine kinase inhibitors and acute pancreatitis. JOP 11:291–293
Riesle E, Friess H, Wagner M, Uhl W, Baczako K, Gold LI, Korc M, Büchler MW (1997) Increased expression of transforming growth factor beta s after acute oedematous pancreatitis in rats suggests a role in pancreatic repair. Gut 40:73–79
Runkel NS, Moody FG, Smith GS, Rodriguez LF, LaRocco MT, Miller TA (1991) The role of the gut in the development of sepsis in acute pancreatitis. J Surg Res 51:18–23
Scartozzi M, Bearzi I, Pierantoni C, Mandolesi A, Loupakis F, Zaniboni A, Catalano V, Quadri A, Zorzi F, Berardi R, Biscotti T, Labianca R, Falcone A, Cascinu S (2007) Nuclear factor-kB tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapy. J Clin Oncol 25:3930–3935
Schmidt J, Rattner DW, Lewandrowski K, Compton CC, Mandavilli U, Knoefel WT, Warshaw AL (1992) A better model of acute pancreatitis for evaluating therapy. Ann Surg 215:44–56
Schreck R, Rieber P, Baeuerle PA (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10:2247–2258
Shah V, Lyford G, Gores G, Farrugia G (2004) Nitric oxide in gastrointestinal health and disease. Gastroenterol. 126:903–913
Shaker MA, Zalata KR, Mehal WZ, Shiha GE, Ibrahim TM (2011) Comparison of imatinib, nilotinib and silymarin in the treatment of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis. Toxicol Appl Pharmacol 252:165–175
Shenkar R, Coulson WF, Abraham E (1994) Anti-transforming growth factor-beta monoclonal antibodies prevent lung injury in hemorrhaged mice. Am J Respir Cell Mol Biol 11:351–357
Siegbahn A, Hammacher A, Westermark B, Heldin CH (1990) Differential effects of the various isoforms of platelet-derived growth factor on chemotaxis of fibroblasts, monocytes, and granulocytes. J Clin Invest 85:916–920
Smotkin J, Tenner S (2002) Laboratory diagnostic tests in acute pancreatitis. J Clin Gastroenterol 34:459–462
Steinle AU, Weidenbach H, Wagner M, Adler G, Schmid RM (1999) NF-kappaB/Rel activation in cerulein pancreatitis. Gastroenterol. 116:420–430
Su K, Cuthbertson C, Christophi C (2006) Review of experimental animal models of acute pancreatitis. PHS 8:264–286
Takahashi N, Miura M, Kuroki J, Mitani K, Kitabayashi A, Sasaki O, Kimura H, Imai K, Tsukamoto N, Noji H, Kondo T, Motegi M, Kato Y, Mita M, Saito H, Yoshida C, Torimoto Y, Kimura T, Wano Y, Nomura J, Yamamoto S, Mayama K, Honma R, Sugawara T, Sato S, Shinagawa A, Abumiya M, Niioka T, Harigae H, Sawada K (2014) Multicenter phase II clinical trial of nilotinib for patients with imatinib-resistant or intolerant chronic myeloid leukemia from the East Japan CML study group evaluation of molecular response and the efficacy and safety of nilotinib. Biomark Res 2:6
Traenckner EB, Wilk S, Baeuerle PA (1994) A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. EMBO J 13:5433–5441
Ueda T, Ho HS, Anderson SE, Takeyama Y (1999) Pancreatitis-induced ascetic fluid and hepatocellular dysfunction in severe acute pancreatitis. J Surg Res 82:305–311
Uruñuela A, Sevillano S, de la Mano AM, Manso MA, Orfao A, de Dios I (2002) Time-course of oxygen free radical production in acinar cells during acute pancreatitis induced by pancreatic duct obstruction. Biochim Biophys Acta 1588:159–164
Viola G, al- Mufti RA, Sohail M, Williamson RC, Mathie RT (2000) Nitric oxide induction in a rat model of selective pancreatic ischemia and reperfusion. Hepato-Gastroenterology 47:1250–1255
Vogelmann R, Ruf D, Wagner M, Adler G, Menke A (2001) Effects of fibrogenic mediators on the development of pancreatic fibrosis in a TGF-beta1 transgenic mouse model. Am J Physiol Gastrointest Liver Physiol 280:G164–G172
Waldthaler A, Schütte K (2010) Causes and mechanisms in acute pancreatitis. Dig Dis 28:364–372
Wallace JL, Miller MJ (2000) Nitric oxide in mucosal defense: a little goes a long way. Gastroenterol 119:512–520
Xie Y, Wang Y, Zong C, Cheng J (2014) Transforming growth factor-beta inhibits heme oxygenase-1 expression in lung fibroblast through nuclear factor-kappa-B-dependent pathway. Pharmacology 93:185–192
Yılmaz EE, Bozdağ Z, Ibiloğlu I, Arıkanoğlu Z, Yazgan ÜC, Kaplan I, Gümüş M, Atamanalp SS (2016) Therapeutic effects of ellagic acid on L-arginine induced acute pancreatitis. Acta Cir Bras 31:396–401
Zhang J, Ning X, Cui W, Bi M, Zhang D, Zhang J (2015) Transforming growth factor (TGF)-beta-induced microRNA-216a promotes acute pancreatitis via Akt and TGF-beta pathway in mice. Dig Dis Sci 60:127–135
Zhang XP, Lin Q, Zhou YF (2007a) Progress of study on the relationship between mediators of inflammation and apoptosis in acute pancreatitis. Dig Dis Sci 52:1199–1205
Zhang XP, Zhang L, Chen LJ, Cheng QH, Wang JM, Cai W, Shen HP, Cai J (2007b) Influence of dexamethasone on inflammatory mediators and NF kappa B expression in multiple organs of rats with severe acute pancreatitis. World J Gastroenterol 13:548–556
Zhao X, Dib M, Andersson E, Shi C, Widegren B, Wang X, Andersson R (2005) Alterations of adhesion molecule expression and inflammatory mediators in acute lung injury induced by septic and non-septic challenges. Lung 183:87–100
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Nader, M.A., Wagih, H.M. Nilotinib, a tyrosine kinase inhibitor exhibits protection against acute pancreatitis-induced lung and liver damage in rats. Naunyn-Schmiedeberg's Arch Pharmacol 390, 291–300 (2017). https://doi.org/10.1007/s00210-016-1327-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-016-1327-2